Literature DB >> 14441532

Distribution of catechol compounds in human brain.

I SANO, T GAMO, Y KAKIMOTO, K TANIGUCHI, M TAKESADA, K NISHINUMA.   

Abstract

Entities:  

Keywords:  BRAIN/metabolism; DOPA/metabolism; NOREPINEPHRINE/metabolism; TYRAMINE/related compounds

Mesh：

Substances：

Year:  1959        PMID： 14441532     DOI： 10.1016/0006-3002(59)90652-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  35 in total

1.  Topographical differences in the cerebral metabolism of DL-2-14C-3,4-dihydroxphenylalanine.

Authors:  A PLETSCHER; K F GEY
Journal:  Experientia       Date:  1962-11-15

2.  The pathogenesis of Parkinson's disease: a new hypothesis.

Authors:  A BARBEAU
Journal:  Can Med Assoc J       Date:  1962-10-13       Impact factor: 8.262

Review 3.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

4.  Regional cerebral metabolic patterns demonstrate the role of anterior forebrain mesocircuit dysfunction in the severely injured brain.

Authors:  Esteban A Fridman; Bradley J Beattie; Allegra Broft; Steven Laureys; Nicholas D Schiff
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-14       Impact factor: 11.205

Review 5.  Brain dopamine neurone 'damage': methamphetamine users vs. Parkinson's disease - a critical assessment of the evidence.

Authors:  Stephen J Kish; Isabelle Boileau; Russell C Callaghan; Junchao Tong
Journal:  Eur J Neurosci       Date:  2016-09-05       Impact factor: 3.386

6.  Approaches to the study of cerebral dopamine metabolism in certain extrapyramidal diseases.

Authors:  V P Barkhatova; E I Kandel'; E G Demina
Journal:  Neurosci Behav Physiol       Date:  1985 Mar-Apr

7.  On the occurence of vanillic acid in human brain and cerebrospinal fluid.

Authors:  G Ebinger; R Verheyden
Journal:  J Neurol       Date:  1976-04-23       Impact factor: 4.849

8.  [Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome].

Authors:  H BERNHEIMER; W BIRKMAYER; O HORNYKIEWICZ
Journal:  Klin Wochenschr       Date:  1961-10-15

Review 9.  Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.

Authors:  Toshiharu Nagatsu; Ikuko Nagatsu
Journal:  J Neural Transm (Vienna)       Date:  2016-08-04       Impact factor: 3.575

10.  [ON THE PRESENCE OF CATECHOLAMINES AND 3,4-DIHYDROXYPHENYLALANINE (DOPA) IN THE EYE].

Authors:  H BERNHEIMER
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.